Immunotherapy in head and neck cancer: current practice and future possibilities
FO Agada, O Alhamarneh, ND Stafford… - The Journal of …, 2009 - cambridge.org
The survival of patients with head and neck squamous cell carcinoma has changed little
over the last 30 years. However, with recent advances in the fields of cellular and molecular …
over the last 30 years. However, with recent advances in the fields of cellular and molecular …
[HTML][HTML] Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development
Y Chen, N Jiang, M Chen, B Sui, X Liu - Frontiers in Cell and …, 2022 - frontiersin.org
The mRNA vaccines have been considered effective for combating cancer. However, the
core components of the mRNA vaccines against head and neck squamous cell carcinoma …
core components of the mRNA vaccines against head and neck squamous cell carcinoma …
[HTML][HTML] Immunotherapeutic strategies for head and neck squamous cell carcinoma (HNSCC): current perspectives and future prospects
L Gao, A Zhang, F Yang, W Du - Vaccines, 2022 - mdpi.com
Neoantigens are abnormal proteins produced by genetic mutations in somatic cells.
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
进展期肿瘤主动特异性免疫治疗的临床研究
姚德茂， 潘承恩， 李瑞祥， 白东晓， 李永利 - 西安交通大学学报: 医学版, 2006 - cqvip.com
目的探讨自体肿瘤疫苗的作用机制. 方法50 例进展期肿瘤患者术后第4 周开始以自体肿瘤细胞
疫苗行主动特异性免疫治疗. 免疫接种共4 次, 每次间隔7—10d; 接种前3d 及第4 次接种后1 周 …
疫苗行主动特异性免疫治疗. 免疫接种共4 次, 每次间隔7—10d; 接种前3d 及第4 次接种后1 周 …
鼻咽癌的免疫治疗进展
邱艳芳， 刘志刚， 赵宇， 王晖 - 中国肿瘤临床, 2016 - cjco.cn
鼻咽癌是一种与EB 病毒(Epstein-Barrvirus, EBV) 相关的恶性肿瘤, 单纯放疗或同步放化疗是鼻
咽癌重要的治疗手段, 且取得较好的疗效, 但局部晚期或远处转移的鼻咽癌患者预后仍较差 …
咽癌重要的治疗手段, 且取得较好的疗效, 但局部晚期或远处转移的鼻咽癌患者预后仍较差 …
放射免疫治疗在头颈鳞状细胞癌中的应用
程俊萍， 杨宝琦 - 国外医学: 耳鼻咽喉科学分册, 2004 - cqvip.com
鳞状细胞癌是头颈肿瘤的主要组织类型, 肿瘤是否有淋巴结转移是评估预后的关键因素.
由于早期诊断的局限性, 当出现局部或远端的肿瘤转移灶时, 预后往往较差 …
由于早期诊断的局限性, 当出现局部或远端的肿瘤转移灶时, 预后往往较差 …
Immunotherapy of patients with head and neck carcinomas
M Tsukuda - Gan to Kagaku ryoho. Cancer & Chemotherapy, 1996 - europepmc.org
The decline of immunity has been reported in head and neck carcinomas in the advanced
stage. On the basis of this finding in head and neck carcinomas, additional immunotherapy …
stage. On the basis of this finding in head and neck carcinomas, additional immunotherapy …
原位疫苗: 肿瘤免疫治疗的新思路.
朱军梦， 刘宝瑞 - Chinese Journal of Cancer Biotherapy, 2020 - search.ebscohost.com
肿瘤免疫治疗的新策略发展迅速, 已经成为肿瘤治疗最受瞩目的领域. 关于如何实现最理想抗
肿瘤免疫效果, 可采用“被动” 免疫疗法如过继性细胞疗法, 基因工程T 细胞等直接攻击肿瘤细胞 …
肿瘤免疫效果, 可采用“被动” 免疫疗法如过继性细胞疗法, 基因工程T 细胞等直接攻击肿瘤细胞 …